CTOs on the Move

Health Republic Insurance

www.healthrepublicny.org

 
Health Republic Insurance of New York is a not-for-profit health insurance CO-OP (Consumer Operated and Oriented Plan) established under the Affordable Care Act to expand affordable healthcare options for all New Yorkers. Our high-quality plans are available to individuals and small groups, both on exchange and off, throughout the state. Since we opened our doors in October of 2013, we`ve enrolled over 145,000 members, making us the largest health insurance cooperative in the country and one of the fastest growing insurance companies in New York history. Our tremendous success is a testament to the way our values resonate with our ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

DentalPlans.com

DentalPlans.com connects individuals, families and groups to savings on dental care procedures, with or without dental insurance. Visitors of DentalPlans.com can compare plans by ZIP code or procedure, view sample savings and find a nearby dentist. The company offers more than 30 Dental Savings Plans from trusted networks available at more than 100,000 participating dentists across the country. As the leading online provider, DentalPlans.com is devoted to improving oral health by making quality dental care affordable and accessible to everyone nationwide.

Cvi Medical Liquidators-Tx

Cvi Medical Liquidators-Tx is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Thrive Affordable Vet Care

THRIVE Vet Care offers high quality vet care at affordable prices in locations near you. Book an appointment online!

Pharmacy Access Solutions

Pharmacy Access Solutions Inc. is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kymera Therapeutics

Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.